Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanoshel is a leading nanotechnology firm that specializes in the research, development, and manufacture of a diverse range of nanomaterials for the life sciences and industrial sectors. The company provides high-purity nanoparticles, carbon nanotubes, and graphene used in drug delivery systems, medical imaging, and antimicrobial applications. Nanoshel's biomedical division focuses on enhancing the bioavailability of therapeutics and developing innovative diagnostic tools. With a global presence and a catalog of thousands of specialized materials, the company supports biotech and pharmaceutical researchers in advancing nanomedicine. Their capabilities include custom synthesis and large-scale production of nanomaterials tailored to specific clinical and research needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanoshel.